Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hubiche

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of the American Academy of Dermatology|August 13, 2022
Association of atypical skin manifestations at the onset of systemic juvenile idiopathic arthritis with difficult-to-treat disease: A retrospective multicenter studyLaurye-Anne Eveillard, Pierre Quartier, Naim Ouldali, et al.
Journal of the American Academy of Dermatology|October 16, 2016
The scalp hair collar and tuft signs: A retrospective multicenter study of 78 patients with a systematic review of the literatureDidier Bessis, Michèle Bigorre, Nausicaa Malissen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 13, 2024
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective StudyAlexandre Beyrouti, Juliette Deuze, Eric Fontas, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 17, 2025
Drug survival of systemic treatments for severe paediatric psoriasis: An international retrospective studyYunyun Miao, Alain Beauchet, Maryam Piram, et al.
Journal of the American Academy of Dermatology|September 29, 2024
Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: A nationwide studyClaire Guillemin, Nathalia Bellon, Marie Jachiet, et al.
BMJ (Clinical Research Ed.)|January 6, 2026
Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trialFranck Boralevi, Guillaume Simon, Charlotte Bernigaud, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of the American Academy of Dermatology|August 13, 2022
Association of atypical skin manifestations at the onset of systemic juvenile idiopathic arthritis with difficult-to-treat disease: A retrospective multicenter studyLaurye-Anne Eveillard, Pierre Quartier, Naim Ouldali, et al.
Journal of the American Academy of Dermatology|October 16, 2016
The scalp hair collar and tuft signs: A retrospective multicenter study of 78 patients with a systematic review of the literatureDidier Bessis, Michèle Bigorre, Nausicaa Malissen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 13, 2024
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective StudyAlexandre Beyrouti, Juliette Deuze, Eric Fontas, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 17, 2025
Drug survival of systemic treatments for severe paediatric psoriasis: An international retrospective studyYunyun Miao, Alain Beauchet, Maryam Piram, et al.
Journal of the American Academy of Dermatology|September 29, 2024
Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: A nationwide studyClaire Guillemin, Nathalia Bellon, Marie Jachiet, et al.
BMJ (Clinical Research Ed.)|January 6, 2026
Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trialFranck Boralevi, Guillaume Simon, Charlotte Bernigaud, et al.
Pageof 7